gal (Gopalakrishnan et al., 1997) , anti-bacterial (Suksamrarn et al., 2003) , neuroprotective (Chairungsrilerd et al., 1998; Pedraza-Chaverri et al., 2009) , and cardioprotective activities (Devi Sampath and Vijayaraghavan, 2007) . In addition, it has been reported that αM and gM have potential anti-cancer effects by inducing apoptosis (Matsumoto et al., 2004; Moongkarndi et al., 2004; Sato et al., 2004; Matsumoto et al., 2005) , cell cycle arrest (Matsumoto et al., 2005; Johnson et al., 2012; Xu et al., 2014) , and autophagic cell death (Chao et al., 2011) . In addition, they can reduce oxidation (Moongkarndi et al., 2004; Jung et al., 2006) , inflammation (Nakatani et al., 2002; Gutierrez-Orozco et al., 2013) , metastasis and invasion (Shibata et al., 2011; Wang et al., 2012) of several cancer cell lines. However, molecular mechanisms of both compounds in pancreatic cancer cells have been reported yet.
Therefore, the objective of this study was to determine the anti-cancer effect of αM and gM extracted from the pericarp of Garcinia mangostana L. on pancreatic cancer cell lines and decipher molecular mechanisms associated with their anti-cancer effect using TUNEL assay, western blotting, and miRNA assay. In addition, anti-cancer effect of a combination of gemcitabine with αM and gM in pancreatic cancer cell lines was determined in this study.
MATERIALS AND METHODS

Cell lines and culture
Human pancreatic cancer cell lines MIA PaCa-2 and PANC-1 were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). These cells were cultured in DMEM (Hyclone, Waltham, MA, USA) supplemented with 10% FBS (Hyclone, Waltham, MA, USA) and 1% penicillin/ streptomycin (Gibco, Invitrogen Inc., Carlsbad, CA, USA) and incubated at 37°C in humidified atmosphere with 5% CO2.
Cell viability
Separation and identification of αM and gM were conducted as described previously (Chae et al., 2016) . Their structures are shown in Fig. 1A and 1B. αM and gM were dissolved in dimethylsulfoxide (DMSO) at 20 mM and stored at 4°C. Cell viability was measured using WST-1 reagent (Roche, Mannheim, Germany). Cells were seeded into 96-well cell culture plates at density of 4,000 to 5,000 cells per well. After incubation for 24 h, cells were treated with αM or gM at various concentrations (1, 5, 10, and 20 µM) . DMSO (0.1% v/v) was used as a negative control. After 48 h or 72 h of treatment, absorbance was measured at wavelength of 450 nm using a microplate reader after 2 h of incubation with 10 µl of WST-1 reagent added to was determined using WST-1 assay at 48 h (C) and 72 h (D) after treatment with αM or gM. It was tabulated with additional IC 50 value (E). All experiments were repeated three times. Circle : MIA PaCa-2; Triangle : PANC-1; Filled : αM; Unfilled : gM. *p<0.05, **p<0.01, and ***p<0.001.
each well. Cell viability was calculated from mean values of three wells. The experiment was repeated three times.
Western blotting
MIA PaCa-2 and PANC-1 cells (2×10 5 cells per well in 6-well plate) were treated with 1, 5, 10, and 20 µM of αM or gM. Cells were lysed in 200 µl RIPA Buffer (Thermo Scientific, Waltham, MA, USA) containing phosphatase inhibitor and protease inhibitor (Roche) for 20 min on ice following the manufacturer's protocol. Protein concentrations were measured using BCA Protein Assay Kit (Thermo Scientific). Total protein (30 µg) was separated by SDS-PAGE and transferred onto PVDF membranes. Membranes were blocked with 5% of nonfat dry milk in TBST at room temperature for more than 1 h and incubated at 4°C overnight with the following primary antibodies: anti-human-Bax, PAPR, cleaved PARP, caspase-3, cleaved caspase-3, LC3II, SQSTM1/P62, AMPKα, phospho-AMPKα, mTOR, phospho-mTOR, p38 MAPK, and phospho-p38 MAPK from Cell Signaling Technology (Beverly, MA, USA), β-Actin from Bioworld Technology (St. Louis Park, MN, USA). Blots were then probed with HRP-conjugated anti-rabbit antibodies from Thermo Scientific or anti-mouse antibodies from Bethyl Laboratories (Montgomery, TX, USA). Blots were visualized using ECL solution (Thermo Scientific).
TUNEL assay
MIA PaCa-2 and PANC-1 cells (1.5×10 4 cells per chamber) were seeded into Chamber Slide (Lab Tek Chamber Slide) for 24 h. Cells were fixed with 4% paraformaldehyde after incubation with αM or gM at IC50 for 48h. They were then subjected to TUNEL assay using In Situ Cell Death Detection Kit, AP (Roche). NBT/BCIP (Roche) was used for staining. DMSO (0.1% v/v) was used as a negative control. IC50 of HS-345 (Seo et al., 2013) was used as a positive control for apoptosis.
RNA extraction
MIA PaCa-2 cells were grown in DMEM media as described above and seeded into 6-well cell culture plates at density of 2×10 5 cells per well. On the following day, cells were treated with αM or gM at 20 µM for 48 h. Total RNA was extracted from cells using Trizol reagent (Invitrogen Inc.) following the manufacturer's instructions. DNA was subsequently removed using DNA-free TM Kit (Invitrogen Inc.) following the manufacturer's protocol.
miRNA PCR array
miScript ® miRNA PCR Array Human miFinder Kit (QIAGEN Inc., Valencia, CA, USA) was used for profiling microRNAs in MIA PaCa-2. Total RNA (250 ng) was used for this experiment. cDNA synthesis and miRNA PCR Array were conducted using Pathway-Focused miScript ® miRNA PCR Arrays (QIAGEN Inc.) following the manufacturer's protocols. SNORD95 was used as an internal control gene. This experiment was repeated twice.
TaqMan miRNA assay
To confirm miRNA PCR Array data, TaqMan miRNA assay was performed. Briefly, 50 ng of total RNA was converted into cDNA using TaqMan ® microRNA Reverse Transcription Kit (Applied Biosystems, Foster city, CA, USA) following the manufacturer's protocol. Real-time PCR was performed in triplicates and 2 -ΔΔCT method (Livak and Schmittgen, 2001 ) was used for relative quantitation of genes. Data were normalized with RNU6B.
Combination study with gemcitabine
Gemcitabine was purchased from Sigma-Aldrich (St. Louis, Mo, USA) and dissolved in DMSO at 10 mM. MIA PaCa-2 and PANC-1 cells were seeded into 96-well cell culture plates at density of 4,000 to 5,000 cells per well. Cells were incubated with gemcitabine only for 48 or 72 h to obtain IC50 value of gemcitabine. Cells were then incubated with a combination of gemcitabine and αM or gM based on the derived IC50 value. Measurement of cell viability was done using WST-1 Assay. Their combinatorial effect was evaluated using combination index (CI) calculated with the following equation: Where (D50)A and (D50)B were concentrations of drug A and drug B alone that reduced cell viability by 50% compared to the control. (DA) and (DB) were concentrations of drug A and drug B in combination producing a 50% reduction in cell viability compared to the control. α was 0 when drug A and B were mutually exclusive. It was 1 when they were mutually non-exclusive. CI<0.8 was considered as having a synergistic interaction. Additive interaction was considered at 0.8<CI<1.2 while antagonistic interaction was considered at CI>1.2 (Chou and Talalay, 1984) .
Statistical analysis
miRNA PCR array was repeated twice. Other experiments were repeated three times. All data are represented as mean ± SD. For comparison between two groups, student t-test was used. Statistical analysis was performed using Microsoft Excel (Microsoft Corporation, Seattle, WA, USA). p-value of less than 0.05, 0.01, and 0.001 were considered statistically significant (*p<0.05; **p<0.01, and ***p<0.001).
RESULTS αM and gM reduced viability of pancreatic cancer cells
Effect of αM and gM on viability of pancreatic cancer cells was investigated using WST-1 Assay. αM and gM reduced cell viabilities (Fig. 1C, 1D ). Cell viability and IC50 values are shown in Fig. 1E . Their cytotoxicity effects were more efficient for MIA PaCa-2 than for PANC-1. Since their cytotoxicity effects appeared sufficiently after 48 h of incubation, further experiments were performed with 48 h of incubation.
αM and gM induced apoptosis of pancreatic cancer cells It has been reported that αM and gM can induce apoptosis of several human cancer cell lines (Matsumoto et al., 2003; Moongkarndi et al., 2004; Sato et al., 2004) . Furthermore, αM has cytotoxic effect on pancreatic cancer cells BxPC3 and PANC-1 through inducing apoptosis and cell cycle arrest (Xu et al., 2014) . To confirm the ability of αM and gM to induce apoptosis of MIA PaCa-2 and PANC-1, TUNEL assay and western blotting were performed. Results of TUNEL assay revealed that treatment with αM or gM resulted in little transition to apoptotic cell death compared to the control (Fig.  2) . Based on western blotting, levels of cleaved Caspase-3 and cleaved PARP (markers of apoptosis) were increased in groups treated with αM or gM. Bax, another marker of apoptosis, was increased in PANC-1 after treatment with αM or gM (Fig. 3) . These results suggest that αM and gM can induce apoptosis of MIA PaCa-2 and PANC-1.
αM and gM induced autophagy through AMPK/mTOR and p38 in pancreatic cancer cells It has been reported that αM has anti-cancer effect through autophagy in glioblastoma in vivo and colon cancer in vitro (Chao et al., 2011; Kim et al., 2012) . Therefore, whether αM and gM could induce autophagy in pancreatic cancer was assessed by western blotting. Treatment with αM or gM at 20 µM significantly increased levels of LC3II, a marker of autophagosome formation during autophagy, in both cell lines (Fig. 4A) . Levels of p62 (SQSTM1), another marker of autophagy (degraded during autophagy), were decreased in MIA PaCa-2, but not in PANC-1 after treatment with αM or gM at 20 µM (Fig.  4A) . These results indicated that autophagy induced by αM or gM might have proceeded to completion only in MIA PaCa-2.
To identify the mechanism of autophagy induced by αM and gM, several proteins were examined. p-AMPK and p-p38 were increased while p-mTOR was decreased at earlier time points (6 h, 12 h, and/or 24 h) after treatment with αM or gM (Fig. 4B) . However, these proteins did not show any changes at 48 h after treatment with αM or gM in most cases. These results indicate that αM and gM can induce autophagy through AMPK/mTOR and p38 pathways.
αM and gM changed expression levels of miRNAs and miR18a might be related to cell death caused by αM and gM
To profile changes in expression levels of miRNAs after αM and gM treatment, miRNA PCR array was conducted. A total of 84 miRNAs were profiled in MIA PaCa-2. Most of these miRNAs were found to be downregulated in response to αM and gM treatment. A total of 14 miRNAs were downregulated while two miRNAs (miR-146a, 302c) were upregulated at more than 2-fold after treatment with αM or gM (Table 1) . TaqMan miRNA assay was carried out to confirm microRNA PCR array results. TaqMan miRNA assay revealed that expression level of miR-18a was decreased after αM and gM treatment (Fig. 5) , consistent with miRNA PCR array results.
Anti-cancer effect of a combination of gemcitabine with αM or gM
Gemcitabine is frequently used in pancreatic cancer treatment. However, it is only marginally effective (Storniolo et al., 1999) . To determine whether αM or gM could sensitize cancer cells to gemcitabine, MIA PaCa-2 or PANC-1 were treated with gemcitabine alone or in combination with αM or gM at IC50 for 72 h. Cell viability was measured (Fig. 6A-6F ) and tabulated with CI value (Fig. 6G) . αM and gM showed synergistic effects for gemcitabine on cell viability of MIA PaCa-2 compared to treatment with gemcitabine alone.
DISCUSSION
Pancreatic cancer is ranked as the fourth leading cause of death (Siegel et al., 2017) . Characteristics of pancreatic cancer such as poor prognosis, late diagnosis, and early metastasis make pancreatectomy impossible in most cases. Pancreatic cancer also shows chemoresistance. Conventional medication gemcitabine exhibits only 12% tumor responsive rate (Storniolo et al., 1999) .
It has been reported that αM and gM from G. mangostana have anti-cancer effects for various cancers, including prostate cancer, glioblastoma, and colon cancer (Chao et al., 2011; Chang and Yang 2012; Johnson et al., 2012) . Although αM has been assessed in pancreatic cancer cells (Xu et al., 2014) , mechanisms involved in the anti-cancer effect of αM and gM on pancreatic cancer cells are not fully understood yet. Furthermore, altered miRNA expression after treatment with αM has not yet been studied in pancreatic cancer, although were observed after treatment with αM or gM for 48h at several concentrations indicated above (A). Several proteins involved in autophagy pathway were also observed after treatment with αM or gM at IC 50 value for certain incubation time indicated above (B). Actin was used as a loading control.
there is one such study in human colon cancer (Nakagawa et al., 2007) . In this study, cytotoxicity effects of αM and gM were determined. Our results confirmed that these compounds had anti-cancer effect on pancreatic cancer cells in vitro. Several studies have reported that αM can induce apoptosis of pancreatic cancer cell lines such as BxPC-3, PANC-1, and ASPC-1 (Hafeez et al., 2014; Xu et al., 2014) . The current study also showed that αM and gM could induce apoptosis of MIA PaCa-2 and PANC-1. Chao et al. (2011) have reported that αM can induce cell death through autophagy in glioblastoma cells. However, the effect of αM and gM on autophagy in pancreatic cancer cells has not been reported yet. Autophagy is generally known as a protective and survival pathway against starvation. However, it has been reported that autophagy can induce cell death. This is referred to as type II programmed cell death (Ouyang et al., 2012) . During autophagy, double-membraned vesicles called autophagosomes are made with long-lived proteins and organelles. These autophagolysosomes are then fused with lysosomes to form autophagosomes. Autophagolysosomes are organelles that can digest their components for recycling (Benbrook and Long, 2012) . There are three modes by which autophagy is initiated to induce formation of autophagosomes. One is dependent on Beclin-1, another marker of autophagy. Another is dependent on Ulk1 complex that is regulated through upstream factors such as AKT/mTOR and AMPK/ mTOR. The third mode is activated by endoplasmic reticulum stress (ER stress) (Schleicher et al., 2010; Macintosh and Ryan, 2013) . In this study, autophagy induced by αM and gM occurred through AMPK/mTOR and p-p38 pathways. LC3I is cleaved to form LC3II which is involved in the formation of autophagosomes. Therefore, LC3II has been used as a main indicator of autophagy (Kabeya et al., 2000) . p62 (SQSTM1) is a ubiquitin binding protein. It is a secondary marker for autophagy. It directly interacts with LC3II in autophagosomes. It is degraded during autophagy processing. A decrease in p62 level means that autophagy is completely done. Incomplete autophagy will lead to accumulation of p62 (Bjorkoy et al., 2006; Pankiv et al., 2007) . To examine whether αM and gM induced autophagy against pancreatic cancer cell lines, expression levels of LC3II and p62 were determined in this study. αM and gM at 20 µM significantly increased LC3II levels in both cell lines. However, p62 level was decreased in MIA PaCa-2, but not in PANC-1. Although αM and gM induced autophagy in both pancreatic cancer cells, autophagy was only completed Assay. CT mean was calculated from three wells. RNU6B was used as a control to determine relative miRNA expression. 2 -ΔΔCT method was used for relative quantitation of miR-18a. Averages were compared to control by Student's t-test. A p-value of less than 0.01 was considered to be statistically significant (**p<0.01).
Biomol Ther, 609-617 (2017) in MIA PaCa-2. miRNAs are small non-coding RNA composed of 20-22 nucleotides (Lagos-Quintana et al., 2001) . They can bind to the 3'UTR of protein coding genes to regulate translation (Lai, 2002) . Expression levels of miRNAs are altered depending on diseases. Numerous studies have shown an association between miRNAs and apoptosis or miRNAs and autophagy (Frankel and Lund, 2012; Li et al., 2012) . However, the mechanisms are not well-understood yet. In this study, expression levels of 84 miRNAs were monitored using miRNA PCR Array and six miRNA candidates were confirmed by TaqMan miRNA Assay. Among these, miR-18a-5p showed correlation between miRNA PCR Array and TaqMan miRNA Assay results. Several reports have shown that miR-18a-5p is related to cell death. Suppression of miR-18a can increase apoptosis (Fujiya et al., 2014; Zhu et al., 2015) . In addition, miR-18a-5p may promote carcinogenesis by directly targeting IRF2 in lung cancer (Liang et al., 2017) and STK4 in prostate cancer (Hsu et al., 2014) . However, several studies have shown that miR-18a can promote apoptosis and act as tumor suppressor (Humphreys et al., 2014; Wu et al., 2015) . Furthermore, it has been reported that an increase in miR-18a can cause autophagy (Qased et al., 2013; Fujiya et al., 2014; Fan et al., 2016) . Since results of the current study on miR-18a and autophagy were different from those of some reports, more experiments are needed to confirm the relation between miR18a and autophagy. miR-18a-5p has about 50 putative target genes commonly predicted by TargetScan (http://targetscan. org/), miRANDA (http://microRNA.org/), and miRDB (http:// miRDB.org/). Out of these possible target genes, homeobox containing 1 (HMBOX1), SH3 binding protein 4 (SH3BP4), and GRB10-interacting GYF protein 1 (GIGYF1) are thought to be associated with autophagy. HMBOX1 is abundantly expressed in the cytoplasm. When it is overexpressed, apoptosis is decreased while autophagy is increased in HUVECs (Ma et al., 2015) . SH3BP4 is a negative regulator of RagGTPases. It inhibits mTORC1 . It may have potential to induce autophagy. GIGYF1 is a new autophagy regulator through subcellular localization of Atg1-Atg13 complex (Kim et al., 2015) .
In summary, our results revealed that αM and gM could induce autophagy and apoptosis in MIA PaCa-2 and PANC-1 cancer cells. In combination with gemcitabine, αM and gM showed synergistic effect in MIA PaCa-2. These results suggest that αM and gM might be promising agents for treating pancreatic cancer. Further studies are needed to confirm the target gene of miR-18a-5p related to autophagy. Gemcitabine in combination with αM (C, D) or gM (E, F) were added to MIA PaCa-2 (C, E) or PANC-1 (D, F) at a constant rate based on each IC 50 value. After incubation for 72 h, cell viability was measured using WST-1 reagent and calculated from mean values of three wells. This experiment was repeated three times. CI value was calculated for combinatorial effect (G). *p<0.05, **p<0.01, and ***p<0.001.
